trospi, chloride - matokeo ya utafutaji kwa

chartwell rx, llc - trospium chloride (unii: 1e6682427e) (trospium - unii:t4y8ork057) - trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency. trospium chloride tablets are contraindicated in patients with: - urinary retention - gastric retention - uncontrolled narrow-angle glaucoma. - known hypersensitivity to the drug or its ingredients. angioedema, rash and anaphylactic reaction have been reported. teratogenic effects pregnancy category c: there are no adequate and well-controlled studies of trospium chloride in pregnant women. trospium chloride should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus. women who become pregnant during trospium chloride treatment are encouraged to contact their physician. risk summary based on animal data, trospium chloride is predicted to have a low probability of increased risk of adverse developmental outcomes, above background risk. adverse developmental findings

Marekani - Kiingereza - NLM (National Library of Medicine)

trospium chloride er- trospium chloride capsule, extended release

bryant ranch prepack - trospium chloride (unii: 1e6682427e) (trospium - unii:t4y8ork057) - trospium chloride extended-release capsules are a muscarinic antagonist indicated for the treatment of overactive bladder (oab) with symptoms of urge urinary incontinence, urgency, and urinary frequency. trospium chloride extended-release capsules are contraindicated in patients with: teratogenic effects pregnancy category c: there are no adequate and well-controlled studies of trospium chloride extended-release capsules in pregnant women. trospium chloride extended-release capsules should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus. women who become pregnant during trospium chloride extended-release capsules treatment are encouraged to contact their physician. trospium chloride was not teratogenic at statistically significant levels in rats or rabbits administered doses up to 200 mg/kg/day. this corresponds to systemic exposures up to approximately 16 and 32 times, respectively (based on auc), the clinical exposure at the maximum recommen